The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form

被引:88
作者
Levisetti, Matteo G.
Suri, Anish
Petzold, Shirley J.
Unanue, Emil R.
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
D O I
10.4049/jimmunol.178.10.6051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several naturally occurring anti-insulin CD4 T cells were isolated from islet infiltrates of NOD mice. In accordance with the results of others, these T cells recognized the segment of the beta-chain from residues 9-23. Peptides encompassing the B:(9-23) sequence bound weakly to I-A (g7) in two main contiguous registers in which two residues at the carboxyl end, P20Gly and P21Glu, influenced binding and T cell reactivity. Naturally occurring insulin-reactive T cells exhibited differing reactivities with the carboxyl-terminal amino acids, although various single residue changes in either the flanks or the core segments affected T cell responses. The insulin peptides represent another example of a weak MHC-binding ligand that is highly immunogenic, giving rise to distinct populations of autoimmune T cells. The Journal of Immunology, 2007, 178: 6051-6057.
引用
收藏
页码:6051 / 6057
页数:7
相关论文
共 45 条
[1]   Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse [J].
Abiru, N ;
Wegmann, D ;
Kawasaki, E ;
Gottlieb, P ;
Simone, E ;
Eisenbarth, GS .
JOURNAL OF AUTOIMMUNITY, 2000, 14 (03) :231-237
[2]   Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide [J].
Alleva, DG ;
Gaur, A ;
Jin, LP ;
Wegmann, D ;
Gottlieb, PA ;
Pahuja, A ;
Johnson, EB ;
Motheral, T ;
Putnam, A ;
Crowe, PD ;
Ling, N ;
Boehme, SA ;
Conlon, PJ .
DIABETES, 2002, 51 (07) :2126-2134
[3]   Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells [J].
Bergerot, I ;
Arreaza, GA ;
Cameron, MJ ;
Burdick, MD ;
Strieter, RM ;
Chensue, SW ;
Chakrabarti, S ;
Delovitch, TL .
DIABETES, 1999, 48 (09) :1720-1729
[4]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[5]   T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage [J].
Carson, RT ;
Vignali, KM ;
Woodland, DL ;
Vignali, DAA .
IMMUNITY, 1997, 7 (03) :387-399
[6]   Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens [J].
CetkovicCvrlje, M ;
Gerling, IC ;
Muir, A ;
Atkinson, MA ;
Elliott, JF ;
Leiter, EH .
DIABETES, 1997, 46 (12) :1975-1982
[7]   A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes [J].
Corper, AL ;
Stratmann, T ;
Apostolopoulos, V ;
Scott, CA ;
Garcia, KC ;
Kang, AS ;
Wilson, IA ;
Teyton, L .
SCIENCE, 2000, 288 (5465) :505-511
[8]  
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[9]   Intranasal administration of insulin peptide B:9-23 protects NOD mice from diabetes [J].
Daniel, D ;
Wegmann, DR .
ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 :371-372
[10]   TGF-β signaling is required for the function of insulin-reactive T regulatory cells [J].
Du, W ;
Wong, FS ;
Li, MO ;
Peng, J ;
Qi, H ;
Flavell, RA ;
Sherwin, R ;
Wen, L .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1360-1370